Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LiveFreely is a private digital health company focused on proactive aging, senior safety, and caregiver support. Its flagship commercial product, BUDDY, is an AI-enabled health assistant that works with mass-market wearables and smartphones to monitor wellness patterns, detect falls and emergencies, provide medication reminders, track geographic boundaries, and alert caregivers or emergency services. The company markets its solution to seniors, families, care facilities, health systems, health plans, and related care organizations. LiveFreely has expanded its platform through the acquisition of Sompo Horizon and the integration of CareGo, broadening its caregiving and care-navigation capabilities and supporting geographic expansion, including Japan and the broader Asia-Pacific region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LiveFreely.